• Return to Headlines

Celgene Corp: The Winning Streak Continues (CELG)

By Amy Schwartz

Shares of Celgene Corp (NASDAQ:CELG) traded today at $95.42, breaking its 52-week high. So far today approximately 865,000 shares have been exchanged, as compared to an average 30-day volume of 10.4 million shares.

Celgene Corp (NASDAQ:CELG) has potential upside of 18.5% based on a current price of $95.42 and analysts' consensus price target of $113.09. Celgene Corp shares have support at the 50-day moving average (MA) of $89.60 and additional support at the 200-day MA of $83.73.

In the past 52 weeks, shares of Celgene Corp have traded between a low of $58.59 and a high of $95.42 and are now at $95.42, which is 63% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.4% while the 200-day MA has risen 0.3%.

Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.

SmarTrend is tracking the current trend status for Celgene Corp and will alert subscribers who have CELG in their portfolio or watchlist when shares have changed trend direction.

Keywords: 52 week high/lows celgene corp

Ticker(s): CELG